- О компании Sysmex
- Устойчивое развитие
- Новости и cобытия
- Центр знаний
- Клиника и лаборатория
- Надежный работодатель
- О компании Sysmex
Select your local website
Отфильтруйте результаты по типу документа и / или рабочей области, чтобы найти то, что вы ищете.
- Диагностические перспективы
Platelet morphology and IPF during treatment with haemodialysis
In patients treated with haemodialysis (HD), the interaction with the dialysis membrane can disturb haemostatic balance. Interaction of platelets with the membrane can lead to platelet activation and adhesion, which both affects membrane performance and the viability of platelets. By looking at platelet characteristics and morphology, as well as markers of platelet activation, this process can be characterized in more detail.
Quantitative and qualitative monitoring of erythropoiesis with RET-He even on XE-2100 and XT-2000i
Detection of functional iron deficiency is a challenging task. Iron deficiency is a major but highly underestimated health problem worldwide, which in the long run can lead to iron deficiency anaemia and impaired erythropoiesis. Assessment of erythropoietic activity is therefore of prime importance in anaemia diagnostics.
- Тканевые жидкости
SEED: Body fluid cell counts – how to perform and interpret the results
This SEED article is meant to explain the findings focused on cell count and differentiation for pleural, ascitic, cerebrospinal and synovial fluid as well as for CAPD. Traditionally, body fluid counts are performed by manual counting under a microscope using a haemocytometer, but laboratories now have the option of automating their manual processes using automated haematology or urinalysis analysers. This SEED summarises the advantages and disadvantages of haemocytometry and Sysmex analysers and explains briefly the XN-BF mode.
SEED: Haematology - Biomedical Validation
Once the analysis results have been technically validated and considered reliable, they can be looked at from a clinical angle to search for suspect results. The task of biomedical validation is to recognise abnormal or conspicuous quantita¬tive results. Based on the findings compiled by the GFHC, there is a new rule set implemented in Extended IPU looking at things such as cut-off values, assessment of previous values or additional patient information. Check out the recommendation from GFHC.
SEED: Internal quality control in haematology – for the sake of the patient
For the sake of the patient - it is of critical importance that physicians and other healthcare personnel are able to confidently rely on laboratory test results in order to make meaningful and safe decisions about the diagnosis and treatment of patients entrusted to their care.